Cannabis Sustainability Symposium Cannabis Sustainability Symposium
Get your ticket or log in to build your agenda.

The Future of Cannabis Medicine

Sativa_3 - Zoom 6
Join on Zoom

Karyemaitre Aliffe
Ethicannons, Praxigen Biomedia, Executive Officer

Dr. Karyemaitre Aliffe is a multilingual physician-scientist who brings life to science, and vitality to our concepts of medicine. His 35+ years experience in natural products research and discovery spirals the globe, from Ivy League Academia and Silicon Valley Biotech, to the remote healing forests of the Amazon, Australia and Africa. From teaching appointments at Harvard and Stanford, Dr. Aliffe has since been welcomed to over 50 countries as a keynote speaker and guest lecturer, giving insightful presentations to governments, institutions, corporations and executives, health professionals and health-focused community groups worldwide.He is presently Chair, Executive Officer at Ethicannos, Praxigen Biomedia. He leads an expert Natural Health Product Development Team, applying translational medicine and integrative neurophysiology to expand the utility of cannabis-based formulations unto enhancement of global human life in fitness and longevity.

Jessica Knox
Doctors Knox, Inc., American Cannabinoid Clinics, and ADVENT Academy, Co-Founder

Dr. Jessica Knox is a proud graduate of Harvard University, where she majored in psychology and played varsity women’s basketball, co-captaining the team her senior year; Tufts University School of Medicine, where she completed a dual degree in medicine and business; and San Diego State University School of Public Health, where she earned her public health degree during her medical residency at University of California San Diego.

After completing her residency in preventive medicine, Dr. Jessica began her study of the endocannabinoid system and cannabinoid medicine alongside her parents and sister, all of whom have also transitioned from conventional western medicine to endocannabinoid care. Dr. Jessica delights in teaching patients, other healthcare professionals, and the public about the power and promise of the endocannabinoid system and its associated toolkit. She has spoken on numerous medical cannabis panels, presented at cannabis conferences nationwide, and appeared on nationally televised programs and global webcasts to discuss the burgeoning field of Endocannabinology.

Dr. Jessica has also developed expertise in the design and delivery of multi-state telemedicine care. During her tenure as medical director at a Silicon Valley teleheath startup, Dr. Jessica oversaw the growth of the telemedicine practice from serving zero patients to over 100,000 patients in just over 3 years.

Founder and previous Executive Director and Director of Research at CG Corrigan Inc.

Golan Vaknin

Golan Vaknin is an entrepreneur and senior executive with a proven management track record and over 12 years of experience in business development in the public and the privet sectors.

Janice M Vaughn-Knox MD
American Cannabinoid Clinics, Co-Founder

Dr Janice spent 32 years as a board-certified anesthesiologist before becoming an Endocannabinologist and Cannabinology specialist.  As a cofounder of the American Cannabinoid Clinics, Dr Janice stresses the importance of understanding  the pharmacology of cannabis and its application to the intricate physiology of the endocannabinoid system and the greater endocannabinoidome.  Dr. Janice feels endocannabinology is here to stay and should become a subspecialty in medical training. As medical care heads to precision care, the understanding physiology will always precede pharmacology.

The use of cannabis as a medicine is here to stay. Both its safety and efficacy have been well established through much anecdotal and clinical experience. This panel will review the current fields of study on cannabis medicine and reveal what the future has in store